You are here: Home - Investing - Experienced Investor - News -

Share Centre stock of the week: Hikma Pharmaceuticals

Written by:
Helal Miah, investment research analyst at The Share Centre, explains why Hikma Pharmaceuticals is stock of the week.

Hikma is a pharmaceuticals company with Middle Eastern origins and is a recent entrant to the FTSE 100. Investors should appreciate that it is very distinct from its larger rivals in that its focus is on both branded and unbranded generic drugs and its sales exposure is geared towards the Middle East, North African and US markets. The group was founded in Jordan in the late seventies and grew as a result of demand for affordable drugs and the needs of a growing population in the region.

The company has performed well over the last two years with group revenue being driven by strong growth in the injectables business. Investors should be aware that there was some disappointment in the group’s October trading update, where sales of colchicine have been slower than expected, mainly due to competition. Despite this, as patented drugs expire, more manufacturing opportunities are arising and so it is likely that generic drugs will continue to take an increasing share of the market and the likes of Hikma Pharmaceuticals should benefit.

The acquisition of Bedford/Ben Venue and Roxane gives the group a further foothold in the US drugs market and integration continues to progress well. We believe there is much more growth to come from the group and as a result we continue to recommend the shares as a ‘buy’ for investors seeking capital growth and willing to accept a medium level of risk.


Related Posts

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Big flu jab price hikes this winter: Where’s cheapest if you can’t get a free vaccine?

Pharmacies, supermarkets and health retailers are starting to offer flu jabs ahead of the winter season, but t...

Is now the time to fix your energy deal?

Fixed energy tariffs all but disappeared during the energy crisis. But now they are back with an increasing nu...

Everything you need to know about the pension triple lock

Retirees are braced to receive another bumper state pension pay rise next year due to the triple lock mechanis...

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

The best student bank accounts in 2023: Cash offers, tastecards and 0% overdrafts

A number of banks are luring in new student customers with cold hard cash this year – while others are compe...

DIY investors: 10 common mistakes to avoid

For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.

Mortgage down-valuations: Tips to avoid pulling out of a house sale

Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?

Money Tips of the Week